17.46
-0.17
(-0.96%)
At close: April 17 at 3:29:13 PM GMT+5:30
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
1,508,687
1,638,549
2,091,698
2,078,605
Total Liabilities Net Minority Interest
541,925
455,689
512,869
489,434
Total Equity Gross Minority Interest
966,762
1,182,860
1,578,829
1,589,171
Total Capitalization
966,762
1,182,860
1,578,829
1,589,171
Common Stock Equity
966,762
1,182,860
1,578,829
1,589,171
Net Tangible Assets
707,345
874,625
1,411,214
1,534,701
Working Capital
-109,810
-35,075
215,487
237,877
Invested Capital
1,187,524
1,400,559
1,780,538
1,783,801
Tangible Book Value
707,345
874,625
1,411,214
1,534,701
Total Debt
220,762
217,699
201,709
194,630
Net Debt
214,676
209,704
91,053
156,243
Share Issued
50,101.24
50,101.24
40,672.67
40,672.67
Ordinary Shares Number
50,101.24
50,101.24
40,672.67
40,672.67
3/31/2021 - 9/21/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NECLIFE.BO Nectar Lifesciences Limited
22.82
-0.31%
SIGACHI.NS Sigachi Industries Limited
42.05
+6.59%
AARTIPHARM.NS Aarti Pharmalabs Limited
733.60
+2.28%
PPLPHARMA.NS Piramal Pharma Limited
220.41
-0.64%
NATCOPHARM.NS NATCO Pharma Limited
827.60
+0.12%
ZYDUSLIFE.NS Zydus Lifesciences Limited
831.55
+1.15%